Kraus Kevin's Insider Trades & SAST Disclosures
Kraus Kevin's most recent trade in 8X8 Inc. was a trade of 1,000 Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kraus Kevin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.81 per share. | 15 May 2025 | 1,000 | 441,767 (0%) | 0% | 1.8 | 1,810 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.67 per share. | 15 Apr 2025 | 1,000 | 442,767 (0%) | 0% | 1.7 | 1,670 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.14 per share. | 15 Mar 2025 | 12,250 | 444,767 (0%) | 0% | 2.1 | 26,215 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.19 per share. | 15 Mar 2025 | 1,000 | 443,767 (0%) | 0% | 2.2 | 2,188 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.34 per share. | 18 Feb 2025 | 1,000 | 457,017 (0%) | 0% | 3.3 | 3,340 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.12 per share. | 15 Feb 2025 | 624 | 458,017 (0%) | 0% | 3.1 | 1,947 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.60 per share. | 15 Jan 2025 | 1,000 | 458,641 (0%) | 0% | 2.6 | 2,600 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.63 per share. | 13 Dec 2024 | 11,070 | 460,641 (0%) | 0% | 2.6 | 29,059 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.65 per share. | 13 Dec 2024 | 1,000 | 459,641 (0%) | 0% | 2.6 | 2,649 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 15 Nov 2024 | 1,000 | 472,275 (0%) | 0% | 2.9 | 2,890 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.81 per share. | 15 Nov 2024 | 564 | 471,711 (0%) | 0% | 2.8 | 1,585 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.10 per share. | 15 Oct 2024 | 1,000 | 473,275 (0%) | 0% | 2.1 | 2,100 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2024 | 200,000 | 483,270 (0%) | 0% | 0 | Common Stock | |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.83 per share. | 15 Sep 2024 | 7,995 | 475,275 (0%) | 0% | 1.8 | 14,661 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.85 per share. | 15 Sep 2024 | 1,000 | 474,275 (0%) | 0% | 1.9 | 1,850 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.70 per share. | 15 Aug 2024 | 1,000 | 283,676 (0%) | 0% | 1.7 | 1,704 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.71 per share. | 15 Aug 2024 | 406 | 283,270 (0%) | 0% | 1.7 | 694 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.33 per share. | 15 Jul 2024 | 1,000 | 284,676 (0%) | 0% | 2.3 | 2,330 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.93 per share. | 17 Jun 2024 | 11,681 | 285,676 (0%) | 0% | 1.9 | 22,507 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.90 per share. | 17 Jun 2024 | 9,391 | 297,357 (0%) | 0% | 1.9 | 17,852 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.93 per share. | 17 Jun 2024 | 9,364 | 306,748 (0%) | 0% | 1.9 | 18,035 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 17 Jun 2024 | 1,000 | 316,112 (0%) | 0% | 2.0 | 2,030 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.86 per share. | 15 May 2024 | 1,000 | 317,512 (0%) | 0% | 2.9 | 2,860 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.70 per share. | 15 May 2024 | 400 | 317,112 (0%) | 0% | 2.7 | 1,078 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.33 per share. | 15 Apr 2024 | 1,000 | 318,512 (0%) | 0% | 2.3 | 2,330 | Common Stock |
| AN2 Therapeutics Inc | Kevin Krause | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| AN2 Therapeutics Inc | Kevin Krause | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 30,000 | 31,914 | - | 0 | Common Stock | |
| AN2 Therapeutics Inc | Kevin Krause | Chief Strategy Officer | 15 Mar 2024 | 30,000 | 31,914 | - | 0 | Common Stock | ||
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.67 per share. | 15 Mar 2024 | 1,433 | 319,512 (0%) | 0% | 2.7 | 3,819 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.67 per share. | 15 Mar 2024 | 1,000 | 321,307 (0%) | 0% | 2.7 | 2,672 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.67 per share. | 15 Mar 2024 | 362 | 320,945 (0%) | 0% | 2.7 | 965 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.69 per share. | 16 Feb 2024 | 487 | 322,307 (0%) | 0% | 2.7 | 1,312 | Common Stock |
| 8X8 Inc. | Kraus Kevin | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.75 per share. | 15 Feb 2024 | 1,000 | 322,794 (0%) | 0% | 2.8 | 2,750 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.50 per share. | 16 Jan 2024 | 1,000 | 323,794 (0%) | 0% | 3.5 | 3,500 | Common Stock |
| AN2 Therapeutics Inc | Kevin Krause | Chief Strategy Officer | 09 Jan 2024 | 7,417 | 1,914 | - | 20.1 | 149,367 | Common Stock | |
| AN2 Therapeutics Inc | Kevin Krause | Chief Strategy Officer | 09 Jan 2024 | 5,000 | 9,331 | - | 6.6 | 33,000 | Common Stock | |
| AN2 Therapeutics Inc | Kevin Krause | Chief Strategy Officer | 09 Jan 2024 | 5,000 | 26,832 | - | - | Stock Option (right to buy) | ||
| AN2 Therapeutics Inc | Krause Kevin | Chief Strategy Officer | 09 Jan 2024 | 2,417 | 49,868 | - | - | Stock Option (right to buy) | ||
| AN2 Therapeutics Inc | Kevin Krause | Chief Strategy Officer | 09 Jan 2024 | 2,417 | 4,331 | - | 0.4 | 1,015 | Common Stock | |
| AN2 Therapeutics Inc | Kevin Krause | Chief Strategy Officer | 02 Jan 2024 | 2,583 | 4,497 | - | 0.4 | 1,085 | Common Stock | |
| AN2 Therapeutics Inc | Kevin Krause | Chief Strategy Officer | 02 Jan 2024 | 2,583 | 1,914 | - | 20.1 | 51,967 | Common Stock | |
| AN2 Therapeutics Inc | Kevin Krause | Chief Strategy Officer | 02 Jan 2024 | 2,583 | 52,285 | - | - | Stock Option (right to buy) | ||
| 8X8 Inc. | Kraus Kevin | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.53 per share. | 18 Dec 2023 | 4,062 | 324,794 (0%) | 0% | 3.5 | 14,355 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.53 per share. | 18 Dec 2023 | 1,209 | 328,856 (0%) | 0% | 3.5 | 4,272 | Common Stock |
| 8X8 Inc. | Kraus Kevin | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.53 per share. | 18 Dec 2023 | 306 | 330,065 (0%) | 0% | 3.5 | 1,081 | Common Stock |
| 8X8 Inc. | Kraus Kevin | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.65 per share. | 12 Dec 2023 | 1,000 | 330,371 (0%) | 0% | 3.7 | 3,650 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.47 per share. | 16 Aug 2023 | 404 | 337,498 (0%) | 0% | 3.5 | 1,401 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.49 per share. | 17 Jul 2023 | 478 | 337,902 (0%) | 0% | 4.5 | 2,145 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 221,100 | 348,017 (0%) | 0% | 0 | Common Stock | |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.85 per share. | 15 Jun 2023 | 5,063 | 342,633 (0%) | 0% | 3.9 | 19,502 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.85 per share. | 15 Jun 2023 | 4,253 | 338,380 (0%) | 0% | 3.9 | 16,381 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.85 per share. | 15 Jun 2023 | 321 | 347,696 (0%) | 0% | 3.9 | 1,236 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Interim Chief Financial Off. | Sale of securities on an exchange or to another person at price $ 3.16 per share. | 16 May 2023 | 402 | 126,917 (0%) | 0% | 3.2 | 1,271 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Interim Chief Financial Off. | Sale of securities on an exchange or to another person at price $ 3.74 per share. | 17 Apr 2023 | 480 | 127,319 (0%) | 0% | 3.7 | 1,797 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Interim Chief Financial Off. | Sale of securities on an exchange or to another person at price $ 4.83 per share. | 16 Mar 2023 | 6,317 | 127,799 (0%) | 0% | 4.8 | 30,528 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Interim Chief Financial Off. | Sale of securities on an exchange or to another person at price $ 6.06 per share. | 16 Feb 2023 | 1,618 | 134,116 (0%) | 0% | 6.1 | 9,809 | Common Stock |
| AN2 Therapeutics Inc | Kevin Krause | Chief Strategy Officer | 15 Feb 2023 | 62,200 | 62,200 | - | - | Stock Option (right to buy) | ||
| 8X8 Inc. | Kevin Kraus | Interim Chief Financial Off. | Sale of securities on an exchange or to another person at price $ 4.58 per share. | 17 Jan 2023 | 1,824 | 133,708 (0%) | 0% | 4.6 | 8,356 | Common Stock |
| 8X8 Inc. | Kevin Kraus | Interim Chief Financial Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 45,977 | 135,836 (0%) | 0% | 0 | Common Stock | |
| 8X8 Inc. | Kevin Kraus | Interim Chief Financial Off. | Sale of securities on an exchange or to another person at price $ 4.73 per share. | 15 Dec 2022 | 304 | 135,532 (0%) | 0% | 4.7 | 1,438 | Common Stock |
| AN2 Therapeutics Inc | Kevin Krause | Chief Strategy Officer | 12 May 2022 | 66,000 | 66,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges